抗精神病药物功能指数 (AFI) 在精神分裂症
Gabriel-Cristian Marinescu1, Petru Iulian Ifteni2, Andreea Teodorescu2
1Dr. Marinescu G Gabriel-Cristian CMI, Pitesti, Romania.
Frontiers in pharmacology
|July 17, 2025
概括
一个新的抗精神病药物功能指数 (AFI) 排名29抗精神病药物用于精神分裂症治疗. 长效注射,特别是阿里皮普拉等D2部分激动剂,显示出改善患者功能最有前途.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 精神分裂症显著损害了患者的功能.
- 目前的抗精神病药物在恢复功能的能力上有所不同.
- 需要一个比较工具来指导治疗选择.
研究的目的:
- 提出一种理论指数,即抗精神病药物功能指数 (AFI),用于预测抗精神病药物在改善精神分裂症患者功能方面的有效性.
- 根据影响功能结果的因素,比较29种第一代和第二代抗精神病药物.
主要方法:
- 通过整合药理动力学,药理动力学,配方,易用性和安全性,开发了抗精神病药物功能指数 (AFI).
- 使用AFI排名第29的抗精神病药物,优先考虑D2部分激动症和不太频繁的管理.
主要成果:
- 美国药物管理协会 (AFI) 认定阿里皮普拉长效注射 (LAI) 是排名第一的抗精神病药物,因为它具有D2部分激动机制和灵活的剂量 (1-2个月).
- 帕利皮里每6个月一次的LAI,由于其不常见的剂量计划,排名很高.
- 第二代LAI抗精神病药物在改善功能方面通常得分最高.
结论:
- AFI为选择抗精神病药物提供了一个框架,以最大限度地提高精神分裂症患者的功能.
- D2部分激素和长效注射配方是关键的药理学和管理优势.
- 这一指数可以帮助精神病医生为精神分裂症患者做出个性化治疗决定.
相关概念视频
01:21Antipsychotic Drugs: Typical and Atypical Agents
326
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
326
01:28Psychosis and Antipsychotic Drugs: Overview
463
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
463
01:26Psychosis: Goals of Pharmacotherapy
212
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
212
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
390
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
390
01:28Drug Therapy
105
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
105
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
993
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
993